Gain Therapeutics

GANXNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$77.630 M

$1.82 +2.25%

Close of 7 Aug 2026

Revenue

—

Not reported

Earnings

-$20.2M

Loss-making

Shares outstanding

42,654,038

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#319Alterity TherapeuticsATHE$80.7M
#320Telomir PharmaceuticalsTELO$79.8M
#321Gain TherapeuticsGANX$77.6M
#322Adicet BioACET$74.7M
#323TalpheraTLPH$74.2M

Where these numbers come from

Share counts and financials for Gain Therapeutics are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.